share_log

Aesther Healthcare Acquisition Corp. (NASDAQ:AEHAW) Short Interest Update

Aesther Healthcare Acquisition Corp. (NASDAQ:AEHAW) Short Interest Update

美思醫療收購股份有限公司 (NASDAQ: AEHAW) 短期利息更新
kopsource ·  2023/02/15 14:52

Aesther Healthcare Acquisition Corp. (NASDAQ:AEHAW – Get Rating) saw a large growth in short interest in January. As of January 31st, there was short interest totalling 24,800 shares, a growth of 37.8% from the January 15th total of 18,000 shares. Based on an average daily trading volume, of 14,200 shares, the short-interest ratio is currently 1.7 days.

Aesther 醫療保健收購公司(NASDAQ:AEHAW-獲取評級)在 1 月份出現了短暫利益的大幅增長。截至 1 月 31 日,短期利息總額為 24,800 股,較 1 月 15 日的總額 18,000 股股份增長 37.8%。根據 14,200 股的平均每日交易量,短息比率目前為 1.7 天。

Aesther Healthcare Acquisition Stock Up 6.2 %

美思醫療收購股價上升 6.2%

Aesther Healthcare Acquisition stock opened at $0.16 on Wednesday. Aesther Healthcare Acquisition has a 52 week low of $0.06 and a 52 week high of $0.33. The stock's fifty day simple moving average is $0.16.

美斯醫療收購股份於週三開盤 0.16 美元。美斯醫療保健收購的 52 週低點為 0.06 美元,52 周高點為 0.33 美元。股票的五十天簡單移動平均線為 0.16 美元。

Further Reading

進一步閱讀

  • Get a free copy of the StockNews.com research report on Aesther Healthcare Acquisition (AEHAW)
  • LCI Industries Diversification Strategy Pays Off
  • Is It Time To Buy The Dip In The Coca-Cola Company
  • Ex-Dividend Date vs. Record Date: What's the Difference?
  • How Does the Consumer Price Index Affect the Stock Market?
  • Are Denny's Corporation Investors Due For A Grand Slam?
  • 獲取有關以斯特醫療保健收購(AEHAW)的研究報告的免費副本
  • LCI 產業多元化策略回報
  • 現在是時候購買可口可樂公司的蘸料了
  • 除息日期與記錄日期:有什麼區別?
  • 消費者價格指數如何影響股票市場?
  • 丹尼的公司投資者是否應獲得大滿貫?

Receive News & Ratings for Aesther Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aesther Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收 Aesther 醫療保健收購的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Aesther 醫療保健收購及相關公司的最新新聞和分析師評級的簡要每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論